Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.47
-$0.52 (-17.39%)
Sep 22, 2026, 2:34 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 660.6K | 806.92K | 766.3K | 1.03M | 589.9K | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651.01K | 605.84K | 486.97K | 414.25K | 416.71K | 388.99K | 332.6K | 349.27K | 287.6K | 191.22K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | n/a | n/a | 9.28K | n/a | n/a | n/a |
Gross Profit | n/a | 806.92K | 766.3K | 1.03M | 589.9K | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651.01K | 605.84K | 486.97K | 406.29K | 416.71K | 388.99K | 323.32K | 349.27K | 287.6K | 191.22K |
Operating Income | -971.69K | -502.12K | -623.03K | -544.73K | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.18K | -1.56M | -847.79K | -2.69M | -1.62M | -1.87M | -1.38M | -1.13M | -1.37M |
Interest Income | n/a | 45.76K | 43.79K | 30.78K | 34.23K | 39.19K | 51.87K | 61.3K | 63.45K | 73.25K | 83.76K | 91.8K | 126.1K | 54.1K | 79.81K | 45.48K | 15.97K | 25.91K | 29.44K | 28.03K | 20.74K | 22.26K |
Pretax Income | -929.7K | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M | -1.35M |
Net Income | -929.7K | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M | -1.35M |
Selling & General & Admin | 1.08M | 647.6K | 615.91K | 815.21K | 657.75K | 656.64K | 705.71K | 745.73K | 1.13M | 834.91K | 952K | 737.24K | 945.95K | 925.74K | 857.17K | 855.28K | 1.03M | 907.31K | 968.29K | 945.12K | 890.7K | 930.58K |
Research & Development | 552.01K | 661.44K | 773.42K | 756.48K | 656.56K | 879.03K | 1.04M | 367.99K | 933.77K | 944.32K | 975.63K | 1.02M | 903.24K | 595.28K | 1.68M | 398.8K | 2.08M | 1.1M | 1.23M | 780.15K | 524.55K | 629.73K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | -488.75K | n/a | 1 | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.63M | 1.31M | 1.39M | 1.57M | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M | 1.78M | 1.93M | 1.76M | 1.85M | 1.52M | 2.05M | 1.25M | 3.1M | 2.01M | 2.2M | 1.73M | 1.42M | 1.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.63M | 1.31M | 1.39M | 1.57M | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M | 1.78M | 1.93M | 1.76M | 1.85M | 1.52M | 2.05M | 1.26M | 3.1M | 2.01M | 2.21M | 1.73M | 1.42M | 1.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.29M | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 851.29K | 874.63K |
Shares Outstanding (Diluted) | 2.29M | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 874.67K | 874.63K |
EPS (Basic) | -0.41 | -0.20 | -0.25 | -0.33 | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.60 | -2.08 | -1.21 | -1.80 | -1.33 | -1.30 | -1.54 |
EPS (Diluted) | -0.41 | -0.20 | -0.25 | -0.33 | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.60 | -2.08 | -1.21 | -1.80 | -1.33 | -1.27 | -1.54 |
EBITDA | -971.69K | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.05M | -1.05M | -843.64K | -1.46M | -796.07K | -2.66M | -1.58M | -1.83M | -1.34M | -1.1M | -1.36M |
EBIT | n/a | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M | -1.37M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.64K | 2.86K | 12.92K | 18.2K | 7.96K | 8.77K | 9.48K | 9.28K | 9.04K | 8.75K | 8.41K |
Add to Watchlist
Select watchlists to add or remove XBIO